IBDEI083 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3648,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,3649,0)
 ;;=711.00^^33^282^52
 ;;^UTILITY(U,$J,358.3,3649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3649,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,3649,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,3649,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,3650,0)
 ;;=461.9^^33^282^53
 ;;^UTILITY(U,$J,358.3,3650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3650,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,3650,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,3650,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,3651,0)
 ;;=091.0^^33^282^57
 ;;^UTILITY(U,$J,358.3,3651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3651,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,3651,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,3651,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,3652,0)
 ;;=097.0^^33^282^55
 ;;^UTILITY(U,$J,358.3,3652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3652,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,3652,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,3652,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,3653,0)
 ;;=094.9^^33^282^56
 ;;^UTILITY(U,$J,358.3,3653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3653,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,3653,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,3653,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,3654,0)
 ;;=097.9^^33^282^54
 ;;^UTILITY(U,$J,358.3,3654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3654,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,3654,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,3654,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,3655,0)
 ;;=463.^^33^282^60
 ;;^UTILITY(U,$J,358.3,3655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3655,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,3655,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,3655,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,3656,0)
 ;;=130.9^^33^282^61
 ;;^UTILITY(U,$J,358.3,3656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3656,1,4,0)
 ;;=4^130.9
 ;;^UTILITY(U,$J,358.3,3656,1,5,0)
 ;;=5^Toxoplasmosis NOS
 ;;^UTILITY(U,$J,358.3,3656,2)
 ;;=^120695
 ;;^UTILITY(U,$J,358.3,3657,0)
 ;;=011.90^^33^282^62
 ;;^UTILITY(U,$J,358.3,3657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3657,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,3657,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,3657,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,3658,0)
 ;;=614.2^^33^282^63
 ;;^UTILITY(U,$J,358.3,3658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3658,1,4,0)
 ;;=4^614.2
 ;;^UTILITY(U,$J,358.3,3658,1,5,0)
 ;;=5^Tubo-Ovarian Abcess
 ;;^UTILITY(U,$J,358.3,3658,2)
 ;;=^107806
 ;;^UTILITY(U,$J,358.3,3659,0)
 ;;=079.99^^33^282^68
 ;;^UTILITY(U,$J,358.3,3659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3659,1,4,0)
 ;;=4^079.99
 ;;^UTILITY(U,$J,358.3,3659,1,5,0)
 ;;=5^Viral Syndrome
 ;;^UTILITY(U,$J,358.3,3659,2)
 ;;=^295798
 ;;^UTILITY(U,$J,358.3,3660,0)
 ;;=070.1^^33^282^21
 ;;^UTILITY(U,$J,358.3,3660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3660,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,3660,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,3660,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,3661,0)
 ;;=070.30^^33^282^22
 ;;^UTILITY(U,$J,358.3,3661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3661,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,3661,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,3661,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,3662,0)
 ;;=070.32^^33^282^23
 ;;^UTILITY(U,$J,358.3,3662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3662,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,3662,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,3662,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,3663,0)
 ;;=070.51^^33^282^24
